Olaparib potentiates the anti-proliferative and anti-metastatic effects of ONC206 in ovarian cancer cells

被引：0
|
作者：
Hawkins, Gabrielle M. [1 ]
Paraghamian, Sarah E. [1 ]
Fan, Yali [1 ]
Sun, Wenchaun [1 ]
Zhang, Xin [1 ]
Prabhu, Varun [2 ]
Allen, Joshua E. [2 ]
Zhou, Chunxiao [1 ]
Bae-Jump, Victoria L. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Oncoceutics, Philadelphia, PA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5336
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5336
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The anti-proliferative and anti-metastatic effects of ONC206 are potentiated by olaparib in serous ovarian cancer
    Hawkins, Gabrielle
    Paraghamian, Sarah
    Sun, Wenchuan
    Prabhu, Varun
    Allen, Joshua
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S288 - S288
  • [2] Morin exerts anti-metastatic, anti-proliferative and anti-adhesive effect in ovarian cancer cells: an in vitro studies
    Nowak, Ewa
    Sypniewski, Daniel
    Bednarek, Ilona
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (03) : 1965 - 1978
  • [3] Morin exerts anti-metastatic, anti-proliferative and anti-adhesive effect in ovarian cancer cells: an in vitro studies
    Ewa Nowak
    Daniel Sypniewski
    Ilona Bednarek
    Molecular Biology Reports, 2020, 47 : 1965 - 1978
  • [4] Role of ClpP in the anti-cancer effects of imipridone ONC201 and ONC206
    Lee, Andrew
    Maranto, Cristina
    Foster, Scott
    Morrow, Sara
    Allen, Joshua E.
    Lanier, Randall
    Sethna, Phiroze
    Prabhu, Varun V.
    CANCER RESEARCH, 2023, 83 (07)
  • [5] A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer
    Paraghamian, Sarah E.
    Qiu, Jianqing
    Hawkins, Gabrielle M.
    Zhao, Ziyi
    Sun, Wenchuan
    Fan, Yali
    Zhang, Xin
    Suo, Hongyan
    Hao, Tianran
    Prabhu, Varun Vijay
    Allen, Joshua E.
    Zhou, Chunxiao
    Bae-Jump, Victoria
    CANCER BIOLOGY & THERAPY, 2023, 24 (01)
  • [6] A novel dopamine receptor D2 antagonist (ONC206) potentiates the effects of olaparib in endometrial cancer.
    Paraghamian, Sarah E.
    Hawkins, Gabrielle M.
    Sun, Wenchuan
    Fan, Yali
    Zhang, Xin
    Suo, Hongyan
    Prabhu, Varun Vijay
    Allen, Joshua E.
    Zhou, Chunxiao
    Bae-Jump, Victoria
    CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [7] ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer
    Tucker, Katherine
    Yin, Yajie
    Staley, Stuart-Allison
    Zhao, Ziyi
    Fang, Ziwei
    Fan, Yali
    Zhang, Xin
    Suo, Hongyan
    Sun, Wenchuan
    Prabhu, Varun Vijay
    Allen, Joshua E.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (02): : 521 - 536
  • [8] Adaptation to dopamine impairs the anti-cancer effect of ONC201 and ONC206
    Zhang, Yiqun
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2022, 82 (12)
  • [9] Assessment of the anti-genotoxic, anti-proliferative, and anti-metastatic potential of crude watercress extract in human colon cancer cells
    Boyd, Lindsay A.
    McCann, Mark J.
    Hashim, Yumi
    Bennett, Richard N.
    Gill, Chris I. R.
    Rowland, Ian R.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2006, 55 (02): : 232 - 241
  • [10] A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumours
    de Souza Queiroz, Karla Cristiana
    Zambuzzi, Willian Fernando
    de Souza, Ana Carolina Santos
    da Silva, Rodrigo Augusto
    Machado, Daisy
    Justo, Giselle Zenker
    Carvalho, Hernandes F.
    Peppelenbosch, Maikel P.
    Ferreira, Carmen Verissima
    CANCER LETTERS, 2007, 258 (01) : 126 - 134
12345